نتایج جستجو برای: cns relapse prophylaxis

تعداد نتایج: 167473  

Journal: :Blood 2006
Yousif Matloub Susan Lindemulder Paul S Gaynon Harland Sather Mei La Emmett Broxson Rochelle Yanofsky Raymond Hutchinson Nyla A Heerema James Nachman Marilyn Blake Linda M Wells April D Sorrell Margaret Masterson John F Kelleher Linda C Stork

The Children's Cancer Group (CCG) 1952 clinical trial for children with standard-risk acute lymphoblastic leukemia (SR-ALL) compared intrathecal (IT) methotrexate (MTX) with IT triples (ITT) (MTX, cytarabine, and hydrocortisone sodium succinate [HSS]) as presymptomatic central nervous system (CNS) treatment. Following remission induction, 1018 patients were randomized to receive IT MTX and 1009...

Ansari Sh, Kiumarsi A, Rostami T,

Abnormalities of the thyroid gland are among the most frequent endocrine complications observed in childhood cancer survivors. We report an 11 years old girl who developed central hypothyroidism and ACTH deficiency during the chemotherapy for CNS relapse of acute lymphoblastic leukemia before receiving radiotherapy. Keywords: Thyroid gland, hypothyroidism, chemotherapy, acute lymphoblastic leu...

2015
Fadi El Karak Elie El Rassy Samer Tabchi Eliane Chouery Andre Megarbane Joseph Kattan

Central nervous system (CNS) relapse is not a rare presentation in acute myeloid leukemia (AML) as its incidence ranges between 2% and 9%. It manifests with meningeal leukemia, cranial nerve palsies or cerebral mesenchymal myeloid sarcoma. We herein report the case of a 69 year-old female that presented a pseudo-Guillain-Barré syndrome masking an AML CNS relapse. Her symptoms completely resolve...

2017
Nathan P. Gossai Peter M. Gordon

Acute lymphoblastic leukemia (ALL) is the most common cancer in children. While survival rates for ALL have improved, central nervous system (CNS) relapse remains a significant cause of treatment failure and treatment-related morbidity. Accordingly, there is a need to identify more efficacious and less toxic CNS-directed leukemia therapies. Extensive research has demonstrated a critical role of...

2009
Donna L. Johnston

To the Editor: We read with interest the article by Chow and Feusner [1] as well as the letter by Kaspers et al. [2] and response from Feusner and Chow [3] regarding isolated central nervous system (CNS) relapse of acute promyelocytic leukemia (APL) in children. They found a total incidence of CNS relapse of 6/431 (1.39%), and in good risk patients an incidence of truly isolated CNS relapse of ...

1999
Dong Jib Na Jong Dae Han Dong Youb Cha In Kwan Song Hwan Won Choi Eun A Chung Chan wook Park Jong Sung Choi

In Plasmodium vivax and Plasmodium ovale malaria, some of the liver stage parasites remain dormant. The activation of these dormant forms (called hypnozoite) can give rise to relapse weeks, months or years after the initial infection. To prevent relapses, a course of primaquine may be given as terminal prophylaxis to patients. Different strains of Plasmodium vivax vary in their sensitivity to p...

Journal: :Journal of Clinical Medicine 2023

Despite highly intensive multimodality treatment regimens, the prognosis of patients with high-risk neuroblastoma (HRNB) and central nervous system (CNS) relapse remains poor. We retrospectively reviewed data from 13 HRNB CNS who received multimodal therapy consolidating haploidentical stem cell transplantation (haplo-SCT) followed by dinutuximab beta ± subcutaneous interleukin-2 (scIL-2). Foll...

Journal: :Oncology 1997
Deborah P Waber Nancy J Tarbell

Long-term neurotoxicity associated with central nervous system (CNS) prophylaxis for childhood acute lymphoblastic leukemia (ALL), primarily involving physical growth and cognitive development, is an ongoing concern. Although contemporary treatment protocols are associated with less severe toxicity than was commonly observed with earlier protocols, there continue to be late effects. When treatm...

Journal: :Journal of Cancer Prevention & Current Research 2016

Journal: :Blood 2011
Gérard Socié Claudia Schmoor Wolfgang A Bethge Hellmut D Ottinger Matthias Stelljes Axel R Zander Liisa Volin Tapani Ruutu Dominik A Heim Rainer Schwerdtfeger Karin Kolbe Jiri Mayer Johan A Maertens Werner Linkesch Ernst Holler Vladimir Koza Martin Bornhäuser Hermann Einsele Hans-Jochem Kolb Hartmut Bertz Matthias Egger Olga Grishina Jürgen Finke

Previous randomized graft-versus-host disease (GVHD)-prophylaxis trials have failed to demonstrate reduced incidence and severity of chronic GVHD (cGVHD). Here we reanalyzed and updated a randomized phase 3 trial comparing standard GVHD prophylaxis with or without pretransplantation ATG-Fresenius (ATG-F) in 201 adult patients receiving myeloablative conditioning before transplantation from unre...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید